Forte Biosciences (FBRX) Revenue & Revenue Breakdown
Forte Biosciences Revenue Highlights
00
Forte Biosciences Revenue by Period
Forte Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | -100.00% |
2018-12-31 | $18.04M | 43890.24% |
2017-12-31 | $41.00K | -16.33% |
2016-12-31 | $49.00K | -3.92% |
2015-12-31 | $51.00K | - |
Forte Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $6.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | -100.00% |
2019-12-31 | $9.00K | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | -100.00% |
2019-03-31 | $9.00K | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | - |
Forte Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HOWL | Werewolf Therapeutics | $19.94M | $1.14M |
ABVC | ABVC BioPharma | $152.43K | $117.14K |
RZLT | Rezolute | - | - |
FBRX | Forte Biosciences | - | - |
CCCC | C4 Therapeutics | - | - |
DBTX | Decibel Therapeutics | - | - |
ERAS | Erasca | - | - |
TPST | Tempest Therapeutics | - | - |
CELC | Celcuity | - | - |
INDP | Indaptus Therapeutics | - | - |
EWTX | Edgewise Therapeutics | - | - |
KTTA | Pasithea Therapeutics | - | - |